DVT can cause a PE
The FDA recently approved Wegovy to reduce the risk of heart attack, stroke, and cardiovascular death in patients with cardiovascular disease and obesity or overweight
Describing herself as largely 'the lab rat' when she joined the diabetes team, Knudsen remembers she spent 'the first year in a cold room with three technicians to screen hundreds of thousands of compounds to see if they could wedge into the GLP-1 receptor and other targets of interest just snugly enough to stimulate insulin secretion.' To help speed up the screening process, Knudsen devised a method to test 96 candidates in one go instead of just one
Linda Moleon, MD explains how GLP-1 medicines lower blood sugar and what that means for postmenopausal women
Foundayo (Orforglipron) Foundayo is a fresh addition and is noted for its conveniencetake it any time, with or without food
Simultaneously, GLP-1 receptor activation suppresses glucagon secretion, slows gastric emptying, and promotes satiety through central nervous system pathways